Monash IVF Group (ASX:MVF) said that the incident at its Brisbane clinic, where an embryo was mistakenly implanted into the wrong patient, resulting in the birth of a child, will not have a material impact on share price, according to a response to an ASX Aware letter filed on Wednesday.
The company said in response to a letter from the ASX that the incident is an isolated incident of human error.
MVF confirmed that an internal investigation is ongoing.
Shares of the company rose 7% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.